Study of seroprevalence of SARS-CoV-2 in Kazakhstan
Kulimbet M. Saliev T. Alimbekova G. Ospanova D. Tobzhanova K. Tanabayeva D. Zhussupov B. Fakhradiyev I.
6 July 2023Cambridge University Press
Epidemiology and Infection
2023#151
This study aimed to analyse the seroprevalence of SARS-CoV-2 in Kazakhstan. This is a cross-sectional study of adult population in Kazakhstan for the period from October 2021 to May 2022. For the study, 6 720 people aged 18 to 69 were recruited (from 17 regions). The demographic data were collected and analysed. Gender was evenly distributed (males 49.9%, females 50.1%). Women exhibited a higher seroprevalence than men (IgM 20.7% vs 17.9% and IgG 46.1% vs 41.5%). The highest prevalence of IgM was found in the age group of 30-39. However, the highest prevalence of IgG was detected in the age group of 60-69. The seroprevalence of IgG increased across all groups (from 39.7% in 18-29 age groups to 53.1% in 60-69 age groups). The odds for a positive test were significantly increased in older age groups 50-59 (p < 0.0001) and 60-69 (p < 0.0001). The odds of a positive test were 1.12 times higher in females compared to males (p = 0.0294). The odds for a positive test were significantly higher in eight regions (Astana, Akmola, Atyrau, Western Kazakhstan region, Kostanai, Turkestan, Eastern Kazakhstan region, and Shymkent) compared to Almaty city. The odds of a positive test were three times higher in Astana and the Western Kazakhstan region than in Almaty city. In urban areas, the odds of a positive test were 0.75 times lower than in rural areas (p < 0.0001). The studys results showed an adequate level of seroprevalence (63%) that exceeds the essential minimum of herd immunity indicators in the country. There was significant geographic variability with a higher prevalence of IgG/IgM antibodies to SARS-CoV-2 in rural areas.
antibodies , asymptomatic , COVID-19 , SARS-CoV-2 , seroprevalence
Text of the article Перейти на текст статьи
B. Atchabarov Scientific-Research Institute of Fundamental and Applied Medicine, S.D. Asfendiyarov Kazakh National Medical University, Almaty, Kazakhstan
Department of Public Health, Public Opinion Research Centre, Almaty, Kazakhstan
Faculty of Medicine and Healthcare, Al-Farabi Kazakh National University, Almaty, Kazakhstan
Department of Chemistry and Biology, Nazarbayev Intellectual School of Chemistry and Biology, Shymkent, Kazakhstan
B. Atchabarov Scientific-Research Institute of Fundamental and Applied Medicine
Department of Public Health
Faculty of Medicine and Healthcare
Department of Chemistry and Biology
10 лет помогаем публиковать статьи Международный издатель
Книга Публикация научной статьи Волощук 2026 Book Publication of a scientific article 2026